Doctors are on the cusp of launching the first new male contraceptive.

Like many people, Deborah Hill Cone admired Jono Pryor's courage in sharing his feelings.

AFT Pharmaceuticals raised new funds through a redeemable share issue to fuel international growth.

AFT Pharmaceuticals expects annual sales to meet analysts' forecasts of about $70 million.

Doctors have expressed concern that the changes could undermine the relationship between women and their GPs.

A protein may be the key to unlocking a regular, healthy circadian rhythm no matter where (or when) in the world you are.

A drug company that made a $34,000-a-vial medicing has agreed to pay $100 million to settle a lawsuit alleging preventing competition.

Outspoken former pharmaceutical executive Martin Shkreli said the national outrage over drug pricing was blown out of proportion.

Pharmac announced today it would start funding the breast cancer drug Perjeta, but 160 Kiwis who have already started treatment won't be eligible.

A major medical marijuana trial is underway in New Zealand - testing the effects of a new cannabis gel on epilepsy patients.

As a nationwide opioid epidemic raged, DEA investigators went after companies distributing millions of highly addictive pills. Then, their cases ground to a halt.

Douglas Pharmaceuticals expects the US market to become its biggest, overtaking the EU in the near future.

NZ Cancer Society medical director Dr Christopher Jackson discusses urgent worries around New Zealand's systems for reviewing and funding ground-breaking new cancer drugs.

Weaning animals from antibiotics in favor of vaccines has become central as resistant superbugs become more prevalent in public spaces.

Ebos Group plans to sell its 270-store Chemmart business to Terry White Group and taking a 50 per cent stake in the enlarged pharmacy chain.

Martin Shkreli pleaded not guilty to a conspiracy charge accusing him of using employees and consultants to conceal his control of Retrophin Inc. stock.

The Auckland-based drug developer posted a $8.9 million operating loss for the year to March 31.

He plays the blues and is credited with figuring out how drug companies can justify hiking prices charged to vulnerable patients.

No argument against the proposed TPP packs more emotional punch than the claim that the deal would be bad for people's health.

The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland, on paper, to reduce its tax bill.

The botox boom is hitting China - where it's the young, not the old getting the jab.

Viagra could be given to women in childbirth to reduce complications and save babies' lives.

Notorious pharmaceuticals businessman Martin Shkreli has offered Kanye West $10 million to buy his album -- but there's a catch -- he doesn't want it released publicly.

Australia's federal government has introduced draft laws allowing the cultivation and supply of marijuana for medicinal or scientific purposes.

Martin Shkreli is being sued by an artist who says his work was used on the Wu-Tang Clan album Shkreli paid $2 million for.

'Pharma-bro' Martin Shkreli has started a Twitter feud with Wu-Tang Clan.

The former chief executive of Turing Pharmaceuticals cannot stay out of the spotlight.

KaloBios Pharmaceuticals Inc. has filed for bankruptcy after the arrest of former CEO Martin Shkreli knocked the biotechnology company's brief revival off course.

Martin Shkreli terminated from drug company after being arrested on fraud charges.

The world's 'most hated CEO' who hiked the price of an essential drug by 5,000 per cent has likened himself to Robin Hood, John D Rockefeller, and the robber barons.